A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 814 participants.
Also called NCT03018938
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 814 participants
- Sponsor
- Registry
-
NCT03018938
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03018938. Randomized; no masking; primary purpose treatment. Start 2017-02-06 (actual); primary completion 2019-02-19 (actual). Results posted on 2020-03-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus
- Acronym
- CLASSIC
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Insulin Analog Mid Mixture
- Intervention (Drug)
- Basal Insulin Analog
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct03018938- Content hash
35e7b560963296317958636c0ff5a6a3b59ed488c18cd1d0b758f34f2311fac2